Get started
Work

Dysbiosis and Associated Stool Features Improve Prediction of Response to Biological Therapy in Inflammatory Bowel Disease

Year: 2023
Type: article
Study design: Observational Study
DOI: 10.1053/j.gastro.2023.11.304
Authors: Clara Caenepeel, Gwen Falony, Kathleen Machiels, Bram Verstockt, Pedro J. Goncalves, Marc Ferrante, João Sabino, Jeroen Raes, Sara Vieira-Silva, Séverine Vermeire
Institutions: Universitair Ziekenhuis Leuven, KU Leuven, Vlaams Instituut voor Biotechnologie, University Medical Center of the Johannes Gutenberg University Mainz, VIB-KU Leuven Center for Microbiology, Pfizer (Belgium), University of Tübingen, Institute of Molecular Biology
Language: English
Subfield: Genetics
Open Access status: bronze
Funders: Amgen, Eli Lilly and Company, Pfizer, Gilead Sciences, Biogen, Celgene, Danone, Mylan, European Resuscitation Council, Celltrion, Fonds De La Recherche Scientifique - FNRS, Fonds Wetenschappelijk Onderzoek, KU Leuven, Vrije Universiteit Brussel, Vlaams Instituut voor Biotechnologie, Vlaamse regering, Dr. Falk Pharma, Genentech, Janssen Pharmaceuticals, H2020 European Research Council
Awards: G1204067529, G4670113300, G6883273562, G7294454499, G8769410688, G969380122
OpenAlex ID: W4389627398
FWCI: 14.6
Cites: 46
Cited by: 88
Related to: 10